The Times Australia
Fisher and Paykel Appliances
The Times World News

.

What is Ryeqo, the recently approved medicine for endometriosis?

  • Written by Nial Wheate, Associate Professor of the School of Pharmacy, University of Sydney
What is Ryeqo, the recently approved medicine for endometriosis?

For women diagnosed with endometriosis it is often a long sentence of chronic pain and cramping that impacts their daily life[1]. It is a condition that is both difficult to diagnose and treat, with many women needing either surgery or regular medication[2].

A medicine called Ryeqo has just been approved for marketing specifically for endometriosis, although it was already available in Australia to treat a different condition.

Women who want the drug will need to consult their local doctor and, as it is not yet on the Pharmaceutical Benefits Scheme, they will need to pay the full cost of the script.

Read more: People with endometriosis and PCOS wait years for a diagnosis – attitudes to women’s pain may be to blame[3]

What does Ryeqo do?

Endometriosis affects 14% of women of reproductive age[4]. While we don’t have a full understanding of the cause, the evidence suggests it’s due to body tissue that is similar to the lining of the uterus (called the endometrium) growing outside the uterus. This causes pain and inflammation, which reduces quality of life and can also affect fertility.

Ryeqo is a tablet containing three different active ingredients: relugolix, estradiol and norethisterone.

Relugolix is a drug that blocks a particular peptide from releasing other hormones. It is also used in the treatment of prostate cancer[5]. Estradiol is a naturally occurring oestrogen hormone in women that helps regulate the menstrual cycle and is used in menopausal hormone therapy[6]. Norethisterone is a synthetic hormone commonly used in birth control medications and to delay menstruation and help with heavy menstrual bleeding[7].

All three components work together to regulate the levels of oestrogen and progesterone in the body that contribute to endometriosis, alleviating its symptoms.

Relugolix reduces the overall levels of oestrogen and progesterone in the body. The estradiol compensates for the loss of oestrogen because low oestrogen levels can cause hot flushes (also called hot flashes) and bone density loss. And norethisterone blocks the effects of estradiol on the uterus (where too much tissue growth is unwanted).

Read more: A new government inquiry will examine women's pain and treatment. How and why is it different?[8]

Is it really new?

The maker of Ryeqo claims it is the first new drug for endometriosis in Australia in 13 years[9].

But individually, all three active ingredients in Ryeqo have been in use since 2019[10] or earlier.

Ryeqo has been available in Australia since 2022[11], but until now was not specifically indicated for endometriosis. It was originally approved for the treatment of uterine fibroids[12], which share some common symptoms[13] with endometriosis and have related causes.

In addition to Ryeqo, current medical guidance lists other drugs that are suitable for endometriosis and some of these have also only been recently approved.

The oral medicine Dienogest[14] was approved in 2021, and there have been a number of injectable drugs for endometriosis recently approved, such as Sayana Press[15] in 2023.

hands taking pill out of contraceptive blister pack
You can’t take the contraceptive pill with Ryeqo but the endometriosis drug could replace it. Shutterstock[16]

How to take it and what not to do

Ryeqo is a once-a-day tablet. You can take it with, or without food, but it should be taken about the same time each day.

It is recommended you start taking Ryeqo within the first five days after the start of your next period. If you start at another time during your period, you may experience initial irregular or heavier bleeding.

Because it contains both synthetic and natural hormones, you can’t use the contraceptive pill and Ryeqo together. However, because Ryeqo does contain norethisterone it can be used as your contraception, although it will take at least one month of use to be effective[17]. So, if you are on Ryeqo, you should use a non-hormonal contraceptive – such as condoms – for a month when starting the medicine.

Ryeqo may be incompatible with other medicines. It might not be suitable for you if you take medicines for epilepsy, HIV and AIDS, hepatitis C, fungal or bacterial infections, high blood pressure, irregular heartbeat, angina (chest pain), or organ rejection. You should also not take Ryeqo if you have a liver tumour or liver disease.

The possible side effects of Ryeqo[18] are similar to those of oral contraceptives. Blood clots are a risk with any medicine that contains an oestrogen or a progestogen, which Ryeqo does. Other potential side effects include bone loss, a reduction in menstrual blood loss or loss of your period.

Read more: What's a TENS machine? Can it help my period pain or endometriosis?[19]

It’s costly for now

Ryeqo can now be prescribed in Australia, so you should discuss whether Ryeqo is right for you with the doctor you usually consult for your endometriosis.

While the maker has made a submission to the Pharmaceutical Benefits Advisory Committee, it is not yet subsidised by the Australian government. This means that rather than paying the normal PBS price of up to A$31.60[20], it has been reported it may cost as much as $135[21] for a one-month supply. The committee will make a decision on whether to subsidise Ryeqo at its meeting next month.

References

  1. ^ impacts their daily life (www.instagram.com)
  2. ^ surgery or regular medication (www.thewomens.org.au)
  3. ^ People with endometriosis and PCOS wait years for a diagnosis – attitudes to women’s pain may be to blame (theconversation.com)
  4. ^ affects 14% of women of reproductive age (www.aihw.gov.au)
  5. ^ treatment of prostate cancer (www.mayoclinic.org)
  6. ^ menopausal hormone therapy (www.menopause.org.au)
  7. ^ delay menstruation and help with heavy menstrual bleeding (www.netdoctor.co.uk)
  8. ^ A new government inquiry will examine women's pain and treatment. How and why is it different? (theconversation.com)
  9. ^ first new drug for endometriosis in Australia in 13 years (www.gedeonrichter.com)
  10. ^ 2019 (link.springer.com)
  11. ^ since 2022 (www.tga.gov.au)
  12. ^ uterine fibroids (www.ema.europa.eu)
  13. ^ common symptoms (www.medicalnewstoday.com)
  14. ^ Dienogest (www.tga.gov.au)
  15. ^ Sayana Press (www.tga.gov.au)
  16. ^ Shutterstock (www.shutterstock.com)
  17. ^ it will take at least one month of use to be effective (www.ebs.tga.gov.au)
  18. ^ side effects of Ryeqo (www.ebs.tga.gov.au)
  19. ^ What's a TENS machine? Can it help my period pain or endometriosis? (theconversation.com)
  20. ^ normal PBS price of up to A$31.60 (www.pbs.gov.au)
  21. ^ cost as much as $135 (www.9news.com.au)

Read more https://theconversation.com/what-is-ryeqo-the-recently-approved-medicine-for-endometriosis-224237

Times Magazine

Can bigger-is-better ‘scaling laws’ keep AI improving forever? History says we can’t be too sure

OpenAI chief executive Sam Altman – perhaps the most prominent face of the artificial intellig...

A backlash against AI imagery in ads may have begun as brands promote ‘human-made’

In a wave of new ads, brands like Heineken, Polaroid and Cadbury have started hating on artifici...

Home batteries now four times the size as new installers enter the market

Australians are investing in larger home battery set ups than ever before with data showing the ...

Q&A with Freya Alexander – the young artist transforming co-working spaces into creative galleries

As the current Artist in Residence at Hub Australia, Freya Alexander is bringing colour and creativi...

This Christmas, Give the Navman Gift That Never Stops Giving – Safety

Protect your loved one’s drives with a Navman Dash Cam.  This Christmas don’t just give – prote...

Yoto now available in Kmart and The Memo, bringing screen-free storytelling to Australian families

Yoto, the kids’ audio platform inspiring creativity and imagination around the world, has launched i...

The Times Features

The rise of chatbot therapists: Why AI cannot replace human care

Some are dubbing AI as the fourth industrial revolution, with the sweeping changes it is propellin...

Australians Can Now Experience The World of Wicked Across Universal Studios Singapore and Resorts World Sentosa

This holiday season, Resorts World Sentosa (RWS), in partnership with Universal Pictures, Sentosa ...

Mineral vs chemical sunscreens? Science shows the difference is smaller than you think

“Mineral-only” sunscreens are making huge inroads[1] into the sunscreen market, driven by fears of “...

Here’s what new debt-to-income home loan caps mean for banks and borrowers

For the first time ever, the Australian banking regulator has announced it will impose new debt-...

Why the Mortgage Industry Needs More Women (And What We're Actually Doing About It)

I've been in fintech and the mortgage industry for about a year and a half now. My background is i...

Inflation jumps in October, adding to pressure on government to make budget savings

Annual inflation rose[1] to a 16-month high of 3.8% in October, adding to pressure on the govern...

Transforming Addiction Treatment Marketing Across Australasia & Southeast Asia

In a competitive and highly regulated space like addiction treatment, standing out online is no sm...

Aiper Scuba X1 Robotic Pool Cleaner Review: Powerful Cleaning, Smart Design

If you’re anything like me, the dream is a pool that always looks swimmable without you having to ha...

YepAI Emerges as AI Dark Horse, Launches V3 SuperAgent to Revolutionize E-commerce

November 24, 2025 – YepAI today announced the launch of its V3 SuperAgent, an enhanced AI platf...